Search for: "Price Appeal"
Results 121 - 140
of 14,483
Sorted by Relevance
|
Sort by Date
11 May 2017, 1:35 pm
The Sprint/Windstream complaint in the US Court of Appeals for the DC Circuit alleges that the FCC decision is "arbitrary, capricious, and an abuse of discretion. [read post]
6 Dec 2007, 3:19 pm
The District Court denied the motion to dismiss the price squeeze claim but certified its order for interlocutory appeal. [read post]
10 Jul 2013, 9:59 pm
Appeals from the Southern District of New York go up to the 2nd Circuit of Appeals. [read post]
21 Jan 2015, 9:13 am
§1291 as an appealable final decision. [read post]
19 Oct 2018, 10:16 am
Supreme Court to revive the state’s law aimed at preventing unwarranted price increases of generic drugs. [read post]
3 Feb 2011, 6:05 am
Judge Charles Price has rejected a request to amend his order, announced last December, that around $100 million in refunds to workers and firms would not be granted. [read post]
16 Sep 2010, 1:58 pm
One of those challenges, filed by counsel for al Bahlul in the Hamdan appeal, sought to remove Chief Judge of the Navy O’Toole as Judge Price’s reporting senior, since both sit on the Court of Military Commission Review. [read post]
18 Feb 2021, 10:31 am
One of those exceptions was discussed in a recent ruling from the United States Court of Appeals for the Federal Circuit. [read post]
17 Aug 2017, 8:14 pm
"Uber wins U.S. court appeal to push price-fixing case to arbitration": Jonathan Stempel of Reuters has this report. [read post]
29 Dec 2010, 2:21 pm
Hire a home stager to fix it up with family appeal. [read post]
17 Jun 2020, 10:00 pm
In an informative decision for challenging rules that portend government overreach, the US Court of Appeals for the District of Columbia Circuit upholds the invalidation of the Centers for Medicare and Medicare Services’ drug pricing disclosure rule as exceeding statutory authority and rejects the government’s frequent reliance for CMS rulemaking authority based on the “efficient administration” of the Medicare program. [read post]
17 Jun 2020, 10:00 pm
In an informative decision for challenging rules that portend government overreach, the US Court of Appeals for the District of Columbia Circuit upholds the invalidation of the Centers for Medicare and Medicare Services’ drug pricing disclosure rule as exceeding statutory authority and rejects the government’s frequent reliance for CMS rulemaking authority based on the “efficient administration” of the Medicare program. [read post]
17 Jun 2020, 10:00 pm
In an informative decision for challenging rules that portend government overreach, the US Court of Appeals for the District of Columbia Circuit upholds the invalidation of the Centers for Medicare and Medicare Services’ drug pricing disclosure rule as exceeding statutory authority and rejects the government’s frequent reliance for CMS rulemaking authority based on the “efficient administration” of the Medicare program. [read post]
17 Jun 2020, 10:00 pm
In an informative decision for challenging rules that portend government overreach, the US Court of Appeals for the District of Columbia Circuit upholds the invalidation of the Centers for Medicare and Medicare Services’ drug pricing disclosure rule as exceeding statutory authority and rejects the government’s frequent reliance for CMS rulemaking authority based on the “efficient administration” of the Medicare program. [read post]
17 Jun 2020, 10:00 pm
In an informative decision for challenging rules that portend government overreach, the US Court of Appeals for the District of Columbia Circuit upholds the invalidation of the Centers for Medicare and Medicare Services’ drug pricing disclosure rule as exceeding statutory authority and rejects the government’s frequent reliance for CMS rulemaking authority based on the “efficient administration” of the Medicare program. [read post]
17 Jun 2020, 10:00 pm
In an informative decision for challenging rules that portend government overreach, the US Court of Appeals for the District of Columbia Circuit upholds the invalidation of the Centers for Medicare and Medicare Services’ drug pricing disclosure rule as exceeding statutory authority and rejects the government’s frequent reliance for CMS rulemaking authority based on the “efficient administration” of the Medicare program. [read post]
23 Nov 2009, 1:53 pm
The United States Court of Appeals for the Second Circuit upheld a U.S. [read post]
3 Aug 2021, 5:02 pm
“Price-fixing suit against big three tuna producers to be reconsidered by federal appeals court”: Bob Egelko of The San Francisco Chronicle has this report on an order granting rehearing en banc that the U.S. [read post]
27 Mar 2020, 4:00 am
In Uber Technologies Pricing Cases, ___ Cal.App.5th ___ (Mar. 23, 2020), the Court of Appeal (First Appellate District, Division One) considered an action against Uber by "several taxi companies and taxi medallion owners" "alleging violation of the Unfair Practices Act’s (UPA) prohibition against below-cost sales (Bus & Prof. [read post]
18 Oct 2012, 9:02 am
The Decision of the Federal Court of Appeal The Federal Court of Appeal allowed the taxpayer’s appeal. [read post]
